Atlas FDA

Synvisc, Synvisc-One

FDA premarket approval P940015/S051 · decided 2023-01-13

Approval details

PMA number
P940015
Supplement
S051
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Synvisc, Synvisc-One
Generic name
Acid, hyaluronic, intraarticular
Applicant
Sanofi Genzyme Corp.
Date received
2022-12-16
Decision date
2023-01-13
Days to decision
28 days
Decision code
OK30
Product code
MOZ
Advisory committee
Orthopedic
Expedited review
No
Location
Cambridge, MA
Statement
Replacement of the water distribution system (piping) used to supply water in the manufacture of Synvisc and Synvisc-One.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.